Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001575872-22-001091
Filing Date
2022-11-14
Accepted
2022-11-14 06:42:46
Documents
42
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gthr-20220930.htm   iXBRL 10-Q 1866505
2 EXHIBIT 31.1 gt001_ex31-1.htm EX-31.1 10397
3 EXHIBIT 31.2 gt001_ex31-2.htm EX-31.2 10553
4 EXHIBIT 32.1 gt001_ex32-1.htm EX-32.1 3516
5 EXHIBIT 32.2 gt001_ex32-2.htm EX-32.2 3457
6 GRAPHIC img01.jpg GRAPHIC 11468
  Complete submission text file 0001575872-22-001091.txt   3864232

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA gthr-20220930.xsd EX-101.SCH 21511
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthr-20220930_cal.xml EX-101.CAL 20503
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthr-20220930_def.xml EX-101.DEF 65037
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthr-20220930_lab.xml EX-101.LAB 148386
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthr-20220930_pre.xml EX-101.PRE 124272
36 EXTRACTED XBRL INSTANCE DOCUMENT gthr-20220930_htm.xml XML 348633
Mailing Address 3051 W 105TH AVENUE UNIT 350251 WESTMINSTER CO 80031
Business Address 3051 W 105TH AVENUE UNIT 350251 WESTMINSTER CO 80031 720-587-5100
GENETHERA INC (Filer) CIK: 0001017110 (see all company filings)

EIN.: 650622463 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27237 | Film No.: 221379921
SIC: 2836 Biological Products, (No Diagnostic Substances)